Literature DB >> 20129538

Cardiac sympathetic imaging with mIBG in heart failure.

Ignasi Carrió1, Martin R Cowie, Junichi Yamazaki, James Udelson, Paolo G Camici.   

Abstract

Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20129538     DOI： 10.1016/j.jcmg.2009.07.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


  53 in total

1.  Cardiac sympathetic imaging with mIBG: a tool for better assessment of the diabetic heart.

Authors:  Ignasi Carrió; Albert Flotats
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

2.  Expanding indications for cardiac MIBG imaging of sympathetic activity.

Authors:  Ignasi Carrió; Albert Flotats
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02       Impact factor: 9.236

3.  Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Sebastian Ewen; Christian Ukena; Bodo Cremers; Carl-Martin Kirsch; Dirk Hellwig; Tareq Eweiwi; Samer Ezziddin; Murray Esler; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2015-10-22       Impact factor: 5.460

4.  First assessment of simultaneous dual isotope (123I/99mTc) cardiac SPECT on two different CZT cameras: A phantom study.

Authors:  Tanguy Blaire; Alban Bailliez; Fayçal Ben Bouallegue; Dimitri Bellevre; Denis Agostini; Alain Manrique
Journal:  J Nucl Cardiol       Date:  2017-03-08       Impact factor: 5.952

Review 5.  Cardiac autonomic innervation.

Authors:  Hina K Jamali; Fahad Waqar; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2016-11-14       Impact factor: 5.952

6.  Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure.

Authors:  Tariq Ahmad; Emily C O'Brien; Phillip J Schulte; Susanna R Stevens; Mona Fiuzat; Dalane W Kitzman; Kirkwood F Adams; William E Kraus; Ileana L Piña; Mark P Donahue; Faiez Zannad; David J Whellan; Christopher M O'Connor; G Michael Felker
Journal:  Circ Heart Fail       Date:  2015-06-01       Impact factor: 8.790

Review 7.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

Review 8.  What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?

Authors:  Fahad Waqar; Stephanie H Dunlap; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2012-12       Impact factor: 5.952

Review 9.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

Review 10.  New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers.

Authors:  Ryohei Kobayashi; Xinyu Chen; Rudolf A Werner; Constantin Lapa; Mehrbod S Javadi; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-13       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.